six
major
caus
diarrhea
calv
less
day
age
enterotoxigen
escherichia
coli
etec
rotaviru
coronaviru
cryptosporidium
parvum
c
parvum
type
ii
salmonella
enterica
enterica
subsp
enterica
serovar
nutrit
regardless
etiolog
calv
diarrhea
often
increas
coliform
bacteri
number
small
intestin
small
intestin
bacteri
overgrowth
associ
alter
small
intestin
function
morpholog
damag
increas
suscept
bacteremia
endotoxemia
import
bacteri
overgrowth
calf
diarrhea
garner
renew
attent
realiz
dlactic
acid
play
import
role
develop
acidemia
calv
diarrhea
product
dlactic
acid
result
bacteri
ferment
gastrointestin
tract
common
find
neonat
calv
without
diarrhea
dlactic
acid
major
compon
acidemia
diarrheic
calv
accompani
system
sign
weak
ataxia
review
focus
adjunct
therapi
diarrhea
first
week
life
therefor
address
efficaci
adjunct
treatment
calf
diarrhea
due
eimeria
bovi
eimeria
zurneii
giardia
duodenali
main
principl
ancillari
treatment
neonat
calv
diarrhea
system
ill
treat
prevent
gramneg
septicemia
bacteremia
decreas
number
coliform
bacteria
proxim
small
intestin
abomasum
increas
nonspecif
resist
provid
nutrient
facilit
repair
damag
intestin
prevent
neg
energi
balanc
provid
analgesia
reduc
stress
calf
administr
antimicrobi
predominantli
gramneg
spectrum
activ
shortterm
administr
nonsteroid
antiinflammatori
agent
flunixin
meglumin
meloxicam
continu
milk
feed
calv
diarrhea
caus
c
parvum
oral
administr
halofuginon
azithromycin
appear
effect
decreas
durat
sever
diarrhea
well
decreas
fecal
oocyst
concentr
environment
contamin
theoret
efficaci
treatment
includ
administr
oral
rehydr
therapi
solut
contain
acet
propion
administr
parenter
b
vitamin
fatsolubl
vitamin
calv
chronic
diarrhea
evid
support
efficaci
corticosteroid
motil
modifi
immunostimul
intestin
protect
absorb
probiot
substanc
treatment
calf
diarrhea
administr
item
current
recommend
although
consid
use
antimicrobi
treat
calf
diarrhea
controversi
indic
systemat
review
literatur
provid
strong
unequivoc
evid
specif
antimicrobi
efficaci
treatment
calf
diarrhea
initi
concern
antimicrobi
use
calf
diarrhea
deriv
result
studi
indic
oral
administr
penicillin
chloramphenicol
neomycin
increas
incid
diarrhea
healthi
calv
produc
malabsorpt
reduc
growth
rate
recent
concern
antimicrobi
use
calf
diarrhea
focus
whether
antimicrobi
administr
promot
antimicrobi
resist
enter
pathogen
facilit
emerg
multipl
resist
strain
salmonella
enterica
subsp
enterica
serovar
typhimurium
newport
import
consider
administ
antimicrobi
part
treatment
calv
diarrhea
administ
direct
label
veterinarian
whenev
possibl
select
antimicrobi
agent
appropri
spectrum
activ
use
dosag
protocol
attain
maintain
effect
therapeut
concentr
site
infect
treat
appropri
durat
avoid
advers
local
system
effect
viol
residu
minim
potenti
transfer
antimicrobi
resist
gene
overarch
philosophi
veterinarian
use
prescrib
antimicrobi
conserv
minim
potenti
advers
effect
anim
human
health
calv
diarrhea
small
intestin
overgrowth
e
coli
bacteria
regardless
incit
caus
diarrhea
fig
system
ill
calv
diarrhea
bacteremia
predominantli
due
e
coli
frequenc
bacteremia
high
enough
treatment
calv
diarrhea
system
ill
indic
decreas
appetit
activ
presenc
fever
includ
routin
treatment
potenti
bacteremia
emphasi
treat
potenti
e
coli
bacteremia
bacteremia
also
suspect
present
calv
clinic
sign
salmonella
diarrhea
although
preval
bacteremia
calv
salmonellosi
appear
determin
clinic
sepsi
score
predict
bacteremia
appear
suffici
accur
guid
antimicrobi
treatment
decis
antimicrobi
treatment
diarrheic
calv
system
ill
focus
e
coli
blood
due
bacteremia
small
intestin
due
bacteri
overgrowth
constitut
two
site
bacteri
infect
fecal
bacteri
cultur
antimicrobi
suscept
test
recommend
calv
diarrhea
fecal
bacteri
popul
accur
reflect
small
intestin
blood
bacteri
popul
breakpoint
suscept
test
result
valid
calv
diarrhea
antimicrobi
efficaci
therefor
best
evalu
clinic
respons
treatment
antimicrobi
treatment
may
also
effect
elimin
dlactateproduc
bacteria
gastrointestin
tract
calv
diarrhea
therebi
hasten
time
cours
clinic
improv
although
supposit
need
verifi
oxytetracyclin
sulfachloropyridiazin
administ
parenter
amoxicillin
chlortetracyclin
neomycin
oxytetracyclin
streptomycin
sulfachloropyridazin
sulfamethazin
tetracyclin
administ
oral
label
us
food
drug
administr
fda
treatment
bacteri
enter
scour
colibacillosi
caus
e
coli
bacteria
suscept
antimicrobi
studi
support
efficaci
parenter
oxytetracyclin
sulfachloropyridiazin
oral
amoxicillin
chlortetracyclin
neomycin
oxytetracyclin
streptomycin
sulfachloropyridiazin
sulfamethazin
tetracyclin
label
dose
treat
calv
natur
acquir
diarrhea
appear
publish
peerreview
journal
oral
amoxicillin
effect
treatment
experiment
induc
diarrhea
efficaci
treatment
natur
acquir
diarrhea
beef
calv
view
appar
lack
publish
studi
document
clinic
efficaci
antimicrobi
label
claim
treatment
natur
occur
calf
diarrhea
health
anim
threaten
suffer
death
may
result
failur
treat
system
ill
calv
extralabel
antimicrobi
use
exclud
prohibit
antimicrobi
justifi
treatment
calf
diarrhea
antimicrobi
administ
calv
diarrhea
exhibit
system
sign
ill
indic
inappet
dehydr
lethargi
pyrexia
fig
blood
mucos
shred
stool
fig
latter
indic
breakdown
bloodgut
barrier
presum
increas
risk
bacteremia
parenter
administr
antimicrobi
prefer
oral
administr
ideal
parenter
antimicrobi
bactericid
predominantli
gramneg
spectrum
ideal
parenter
antimicrobi
also
excret
activ
form
bile
result
local
antimicrobi
effect
small
intestin
current
evid
suggest
antimicrobi
administ
diarrheic
calv
normal
appetit
activ
level
rectal
temperatur
hydrat
statu
absenc
concurr
infect
pneumonia
omphalophleb
fig
instead
calv
separ
calv
health
statu
monitor
frequent
success
antimicrobi
therapi
vari
rout
administr
whether
antimicrobi
dissolv
milk
oral
electrolyt
solut
water
oral
antimicrobi
administ
bolu
tablet
gelatin
capsul
mayb
swallow
rumen
exhibit
differ
serum
concentrationtim
profil
antimicrobi
dissolv
milk
replac
suckl
calf
antimicrobi
bypass
rumen
thought
alter
rumen
microflora
potenti
permit
bacteri
recolon
small
intestin
rumen
individu
antimicrobi
treatment
sick
calv
increas
level
resist
fecal
e
coli
isol
chang
antimicrobi
suscept
transient
first
choic
antimicrobi
treatment
diarrhea
system
ill
calv
includ
parenter
amoxicillin
ampicillin
mgkg
intramuscularli
im
everi
hour
parenter
potenti
sulfonamid
mgkg
iv
im
everi
hour
oral
amoxicillin
trihydr
mgkg
everi
hour
alon
combin
inhibitor
clavulan
potassium
mg
combin
drugkg
everi
hour
second
choic
antimicrobi
countri
cephalosporin
administr
permit
third
fourth
gener
cephalosporin
ceftiofur
cefquinom
parenter
ceftiofur
evid
efficaci
experimentallyinduc
fig
jersey
calf
diarrhea
system
sign
ill
calf
reluct
stand
weak
suckl
reflex
current
knowledg
indic
calf
benefit
parenter
antimicrobi
administr
amoxicillin
ampicillin
third
fourth
gener
cephalosporin
countri
use
permit
parenter
fluoroquinolon
administr
indic
calf
need
intraven
fluid
therapi
enterica
subsp
enterica
serovar
dublin
infect
last
choic
antimicrobi
fluoroquinolon
countri
fluoroquinolon
administr
permit
treat
calv
e
coli
diarrhea
salmonellosi
howev
parenter
fluoroquinolon
administ
critic
ill
calv
calv
requir
intraven
fluid
administr
aminoglycosid
also
administ
oral
poorli
absorb
gastrointestin
tract
aminoglycosid
administ
parenter
prolong
withdraw
time
slaughter
potenti
nephrotox
dehydr
calv
minim
excret
bile
result
survey
italian
cattl
veterinarian
indic
fluoroquinolon
aminoglycosid
first
choic
antimicrobi
treat
calf
diarrhea
respond
respect
even
though
oral
parenter
fluoroquinolon
document
efficaci
treat
calv
diarrhea
system
ill
extralabel
administr
fluoroquinolon
foodproduc
anim
unit
state
prohibit
law
concern
regard
facilit
emerg
bacteria
multipl
fig
holsteinfriesian
calf
profus
wateri
diarrhea
contain
blood
calf
admit
later
recumb
pyrex
markedli
depress
inappet
calf
treat
intraven
l
sodium
bicarbon
solut
contain
glucos
abl
stand
within
hour
treatment
current
knowledg
indic
calf
treat
parenter
antimicrobi
nonsteroid
antiinflammatori
agent
meloxicam
flunixin
meglumin
parenter
fluoroquinolon
third
fourth
gener
cephalosporin
administr
may
indic
countri
administr
permit
calf
need
intraven
fluid
therapi
extralabel
administr
fluoroquinolon
food
produc
anim
unit
state
prohibit
law
concern
regard
facilit
emerg
bacteria
multipl
antimicrobi
resist
particularli
pathogen
enter
bacteria
human
antimicrobi
resist
particularli
pathogen
enter
bacteria
human
anoth
import
issu
potenti
ban
extralabel
use
cephalosporin
unit
state
time
articl
written
us
fda
propos
final
rule
prohibit
use
extralabel
cephalosporin
food
produc
anim
third
fourth
gener
cephalosporin
specif
approv
treatment
diarrhea
calv
use
would
permit
rule
amend
diarrhea
accompani
intestin
cramp
abdomin
pain
administr
effect
analges
may
therefor
benefici
part
treatment
calf
diarrhea
provid
side
effect
treatment
deleteri
meloxicam
analges
antiinflammatori
agent
label
europ
treatment
calf
diarrhea
use
conjunct
oral
rehydr
therapi
random
multiloc
trial
calv
europ
singl
iv
inject
meloxicam
mgkg
bodyweight
conjunct
standard
treatment
oral
electrolyt
rehydr
solut
therapi
parenter
gentamicin
increas
feed
intak
hydrat
score
fecal
consist
decreas
sign
viscer
pain
rel
standard
treatment
alon
recent
random
studi
calv
ontario
canada
subcutan
administr
meloxicam
mgkg
result
treat
calv
consum
starter
ration
earlier
placebotr
calv
treat
calv
also
improv
starter
ration
intak
higher
bodi
weight
gain
increas
activ
level
placebotr
calv
taken
togeth
result
suggest
meloxicam
consid
part
initi
treatment
calv
diarrhea
system
ill
countri
meloxicam
label
use
calv
two
broad
categori
antiinflammatori
agent
could
potenti
use
part
treatment
calf
diarrhea
corticosteroid
nonsteroid
antiinflammatori
agent
nsaid
major
therapeut
goal
antiinflammatori
administr
decreas
inflamm
gastrointestin
tract
amelior
effect
endotoxemia
septicemia
secondari
transloc
enter
bacteria
across
damag
intestin
epithelium
although
studi
evalu
preval
endotoxemia
calv
diarrhea
appear
done
result
recent
studi
neonat
lamb
diarrhea
indic
affect
lamb
frequent
endotoxem
assess
limulu
amoebocyt
lysat
assay
routin
administr
corticosteroid
diarrheic
calv
recommend
calv
diarrhea
higher
plasma
corticosteroid
concentr
rel
healthi
calv
corticosteroid
suppress
immun
system
routin
administr
nsaid
meloxicam
flunixin
meglumin
recommend
part
initi
treatment
calv
diarrhea
system
ill
empir
guidelin
treatment
diarrhea
administ
meloxicam
dose
mgkg
bodyweight
mglb
flunixin
meglumin
dose
mgkg
mglb
exceed
dose
either
meloxicam
flunixin
meglumin
recommend
base
need
avoid
damag
abomas
mucosa
particularli
intens
calfrear
facil
histori
calf
death
due
perfor
abomas
ulcer
benefici
effect
meloxicam
flunixin
meglumin
could
caus
analges
antiinflammatori
antipyret
antisecretori
properti
due
underdetermin
effect
intestin
motil
current
clear
potenti
effect
import
administr
one
dose
flunixin
meglumin
mgkg
mglb
intramuscularli
adjunct
treatment
natur
occur
diarrhea
result
fewer
morbidday
antimicrobi
treatment
calv
fresh
blood
visibl
fece
calv
administ
sta
toxin
model
experiment
induc
etec
infect
intramuscular
administr
flunixin
meglumin
mgkg
mglb
everi
hour
reduc
fecal
output
possibl
act
antisecretori
agent
blockad
cyclooxygenas
isoform
requir
facilit
uptak
sodium
intestin
ileum
calv
diarrhea
due
c
parvum
clinic
relev
find
remain
unclear
ileum
quantit
import
site
fluid
flux
calv
diarrhea
dose
need
effect
vitro
blockad
relat
obtain
vivo
use
standard
dosag
protocol
meloxicam
flunixin
meglumin
import
effect
flunixin
meglumin
administr
clinic
impress
calv
show
improv
suckl
behavior
gener
well
treatment
calv
administ
high
dose
ketoprofen
mgkg
bodyweight
iv
twice
hour
apart
tend
p
reduc
fecal
output
rel
untreat
control
wherea
lower
dose
ketoprofen
mgkg
bodyweight
iv
twice
hour
apart
effect
oral
administ
aspirin
acetylsalicyl
acid
mgkg
bodyweight
effect
decreas
stainduc
intestin
secret
calv
wherea
intraven
administ
sodium
salicyl
effect
administ
dose
calcul
maintain
therapeut
serum
salicyl
concentr
mgml
subsalicyl
compon
bismuth
subsalicyl
peptobismol
unit
state
believ
exert
similar
effect
aspirin
bismuth
subsalicyl
may
therefor
decreas
intestin
epitheli
secret
mediat
camp
cgmp
calv
diarrhea
although
verifi
appear
persuas
reason
prefer
bismuth
subsalicyl
aspirin
ketoprofen
meloxicam
flunixin
meglumin
ancillari
treatment
calf
diarrhea
data
avail
bismuth
subsalicyl
aspirin
ketoprofen
recommend
ancillari
treatment
calf
diarrhea
specif
therapi
presum
cryptosporidi
infect
calv
remain
activ
area
research
result
studi
indic
halofuginon
azithromycin
possibl
lasalocid
effect
treatment
cryptosporidi
diarrhea
calv
current
believ
fresh
cow
milk
fed
small
quantiti
sever
time
daili
optim
digest
minim
loss
bodi
weight
feed
cow
milk
may
also
benefici
sourc
dietari
lipid
shown
potent
inhibitor
cryptosporidiumhost
cell
adhes
vitro
halofuginon
quinazolin
unknown
mode
action
licens
number
countri
europ
prevent
treatment
cryptosporidiosi
newborn
calv
halofuginon
mgkg
bodyweight
mouth
daili
improv
clinic
statu
decreas
fecal
oocyst
excret
mortal
dosedepend
manner
calv
experiment
induc
cryptosporidi
infect
toxic
studi
indic
mgkg
daili
mouth
close
toxic
dose
halofuginon
mg
oral
daili
approxim
day
day
life
equival
mgkg
bodyweight
daili
efficaci
decreas
oocyst
excret
effect
preval
diarrhea
fecal
water
percentag
sever
dehydr
natur
infect
calv
quebec
compar
untreat
control
contrast
result
larg
studi
czech
republ
indic
halofuginon
mgkg
bodyweight
daili
day
oral
decreas
intens
diarrhea
fecal
oocyst
count
start
day
day
life
preponder
evid
indic
halofuginon
mgkg
bodyweight
daili
oral
effect
treatment
cryptosporidi
diarrhea
calv
azithromycin
gcalf
oral
daili
day
equival
mgkg
daili
decreas
mortal
rate
fecal
oocyst
shed
increas
clinic
health
weight
gain
calv
natur
acquir
c
parvum
infect
turkey
azithromycin
macrolid
antibiot
well
absorb
small
intestin
like
prokinet
antimicrobi
effect
base
structur
similar
erythromycin
result
studi
suggest
azithromycin
effect
treatment
cryptosporidi
diarrhea
calv
howev
macrolid
wide
use
treatment
respiratori
diseas
human
expens
administr
azithromycin
restrict
sick
calv
document
cryptosporidi
diarrhea
respond
treatment
oral
halofuginon
decoquin
hydroxyquinolon
inhibit
cytochromemedi
electron
transport
mitochondria
use
prevent
treat
cryptosporidia
calv
howev
decoquin
mg
oral
daili
approxim
day
day
life
solid
premix
equival
mgkg
bodyweight
daili
effect
oocyst
excret
preval
diarrhea
fecal
water
percentag
sever
dehydr
calv
compar
untreat
control
decoquin
mgkg
bodyweight
oral
daili
approxim
day
onward
life
solubl
formul
milk
replac
effect
oocyst
excret
total
number
day
diarrhea
mortal
rate
calv
compar
untreat
control
studi
suggest
decoquin
effect
treatment
cryptosporidi
diarrhea
calv
paromomycin
sulfat
solut
mg
paromomycinkg
bodyweight
mouth
daili
day
effect
decreas
oocyst
excret
preval
diarrhea
lamb
natur
acquir
c
parvum
diarrhea
paromomycin
aminoglycosid
antibiot
poorli
absorb
gastrointestin
tract
efficaci
treat
immunocomprom
human
cryptosporidosi
mechan
paromomycin
effect
remain
unknown
lasalocid
ionophor
effect
treatment
natur
acquir
experimentallyinduc
cryptosporidi
diarrhea
calv
daili
oral
dose
rate
mgkg
bodyweight
uncontrol
trial
calv
turkey
natur
acquir
c
parvum
diarrhea
oral
administr
lasolocid
mgkg
bodyweight
daili
milk
associ
decreas
fecal
oocyst
count
although
decreas
like
occur
untreat
calv
agerel
chang
fecal
oocyst
shed
becom
increasingli
evid
past
year
damag
intestin
need
metabol
fuel
optim
repair
fresh
cow
milk
provid
excel
inexpens
readili
avail
sourc
nutrit
growth
factor
facilit
repair
milk
also
energi
dens
oral
rehydr
therapi
ort
solut
continu
milk
feed
minim
weight
loss
associ
chronic
diarrhea
calv
concurr
feed
milk
ort
solut
result
improv
intestin
morpholog
compar
ort
solut
alon
glutamin
supplement
investig
ancillari
treatment
calf
diarrhea
result
two
studi
indic
addit
glutamin
deleteri
effect
small
intestin
villu
height
villu
surfac
area
glutaminetr
calv
lower
mitot
rate
small
intestin
control
calv
current
believ
glutamin
offer
advantag
improv
gut
morpholog
diarrheic
calv
parenter
administr
bvitamin
fatsolubl
vitamin
may
benefici
effect
calv
chronic
diarrhea
howev
lack
data
support
benefici
effect
vitamin
treatment
calf
diarrhea
oligosaccharid
sugar
polym
present
cow
milk
contain
small
number
usual
ten
compon
sugar
either
oor
nlink
compat
amino
acid
protein
call
glycoprotein
lipid
mani
gramneg
bacteria
attach
intestin
epithelium
via
receptor
similar
structur
oligosaccharid
milk
oligosaccharid
may
provid
competit
bind
site
fimbra
enterotoxigen
e
coli
bacteria
bound
oligosaccharid
move
along
intestin
intestin
peristalsi
elimin
fece
oligosaccharid
enzymat
digest
small
intestin
administr
exogen
oligosaccharid
water
neonat
calv
decreas
intestin
e
coli
count
small
intestin
calv
inocul
etec
prophylact
addit
exogen
oligosaccharid
milk
replac
result
fecal
score
scour
calv
similar
observ
calv
fed
milk
replac
contain
antibiot
must
note
data
morbid
mortal
either
low
remain
undetermin
studi
scour
may
well
nutrit
rather
infecti
origin
oligosaccharid
show
promis
nonantimicrobi
method
prevent
etec
treat
etec
diarrhea
calv
howev
experiment
studi
perform
date
support
routin
administr
oligosaccharid
sick
calv
diarrhea
nonspecif
resist
confer
factor
low
abomas
ph
short
chain
fatti
acid
acet
propion
lactoferrin
leukocyt
colostrum
oligosaccharid
colostrum
fresh
milk
lactoperoxidas
system
lysozym
medium
chain
fatti
acid
particularli
ndecano
noctan
acid
fresh
milk
abomas
ph
calf
birth
colostrum
ingest
rang
first
hour
life
mean
preprandi
ph
constant
day
life
rel
high
ph
first
day
life
ensur
ingest
colostr
immunoglobulin
minim
degrad
arriv
small
intestin
site
immunoglobulin
absorpt
unfortun
high
abomas
ph
also
allow
ingest
e
coli
salmonella
spp
escap
abomas
steril
larg
number
viabl
pathogen
bacteria
therefor
arriv
small
intestin
colostrum
heavili
contamin
outlin
follow
section
administr
acidifi
ort
solut
avail
acidifi
water
milk
replac
acidifi
small
intestin
lumen
like
benefici
treatment
diarrhea
due
e
coli
salmonella
inde
acidifi
water
gain
widespread
accept
simpl
effect
method
decreas
incid
sever
diarrhea
wean
pig
acidifi
small
intestin
lumen
e
coli
caus
two
common
diseas
neonat
calv
etec
bacteria
local
lumen
mucos
surfac
small
intestin
colisepticemia
bacteria
invad
system
circul
main
featur
pathogenesi
etec
diarrhea
ingest
etec
passag
low
ph
environ
abomasum
attach
fimbra
epitheli
cell
ileum
colon
progress
anterior
movement
colon
involv
entir
small
intestin
product
heat
stabl
enterotoxin
sta
bind
sta
intestin
epitheli
cell
stimul
secret
chain
event
lead
acut
profus
wateri
diarrhea
death
sever
case
main
featur
pathogenesi
colisepticemia
ingest
serum
resist
strain
e
coli
passag
low
ph
environ
abomasum
multipl
small
intestin
lumen
transloc
across
intestin
epithelium
produc
bacteremia
septicemia
mix
enter
infect
commonli
diagnos
diarrheic
calv
primari
viral
damag
facilit
small
intestin
overgrowth
e
coli
turn
exacerb
morpholog
damag
predispos
calf
colisepticemia
e
coli
bacteremia
e
coli
bacteri
number
increas
fold
lumen
duodenum
jejunum
ileum
calv
natur
acquir
diarrhea
even
diarrhea
due
etec
fig
calv
natur
acquir
diarrhea
increas
small
intestin
colon
e
coli
associ
impair
glucos
xylos
fat
absorpt
calv
etec
nonetec
diarrhea
therefor
increas
number
e
coli
bacteria
small
intestin
increas
deleteri
calf
health
growth
rate
viabil
e
coli
vari
markedli
ph
gastric
juic
aspir
human
infant
ph
minut
bactericid
gramneg
bacteria
increas
ph
associ
increas
growth
rate
gramneg
bacteria
fastest
growth
rate
occur
ph
unpublish
studi
use
small
number
bovin
etec
colisepticem
strain
cultur
abomas
content
fluid
e
coli
kill
ph
multipli
ph
r
relat
unpublish
vivo
studi
constabl
abomas
lumin
ph
influenc
number
e
coli
recov
abomasum
small
intestin
calv
infect
mixtur
etec
colisepticem
strain
abomas
ph
inoculum
dose
recov
etec
strain
resist
phmediat
kill
colisepticem
strain
abomas
lumin
ph
etec
colisepticem
strain
prolifer
taken
togeth
studi
suggest
e
coli
kill
ph
multipli
ph
r
abomasum
anterior
small
intestin
suckl
calf
much
acid
caudal
aspect
intestin
tract
fig
preliminari
data
magnitud
rel
acid
proxim
small
intestin
obtain
healthi
calv
age
day
four
calv
age
day
alimentari
tract
ph
measur
hour
ingest
milk
follow
median
valu
abomasum
small
intestin
divid
equal
part
orad
aborad
larg
intestin
rectum
anoth
studi
median
small
intestin
ph
fast
suckl
calv
distanc
abomasum
ileum
mean
duoden
ph
hour
feed
also
decreas
age
day
day
day
bovin
etec
strain
express
pili
ph
rel
acid
proxim
small
intestin
explain
etec
bacteria
first
colon
distal
small
intestin
follow
anterior
progress
bacteri
adhes
maintain
lumin
ph
therefor
increas
nonspecif
resist
etec
diarrhea
decreas
proxim
intestin
ph
also
decreas
sta
product
attach
etec
product
sta
enterotoxin
greatli
decreas
ph
fig
ph
intestin
content
milk
fed
calv
suckl
cow
milk
time
hour
note
ph
fluctuat
milk
feed
abomasum
anterior
small
intestin
stabl
distal
half
small
intestin
note
also
lumin
ph
becom
increasingli
alkalin
move
aborad
duodenum
toward
ileum
reprint
mylrea
pj
gastrointestin
disord
function
digest
tract
young
calv
re
vet
sci
permiss
sta
toxin
much
potent
secretagogu
proxim
small
intestin
although
sta
receptor
affin
densiti
greatest
ileum
distal
jejunum
neonat
calf
studi
use
ligat
intestin
segment
jersey
calv
age
day
holstein
calv
age
day
inocul
etec
much
larger
secretori
volum
obtain
segment
proxim
small
intestin
termin
jejunum
ileum
produc
littl
volum
follow
inocul
mean
volum
secret
small
intestin
follow
etec
inocul
follow
intestin
divid
six
equal
part
orad
aborad
ml
colon
proxim
intestin
therefor
critic
determin
sever
dehydr
follow
infect
etec
colon
ileum
distal
jejunum
etec
minim
effect
hydrat
statu
sta
ineffect
secretagogu
section
intestin
tract
summari
decreas
lumin
ph
proxim
small
intestin
increas
nonspecif
resist
etec
prevent
adher
epitheli
cell
pili
prevent
secret
sta
enterotoxin
observ
suggest
feed
ort
solut
water
acid
ph
benefici
treat
prevent
calf
diarrhea
moreov
alkalin
induc
bicarbonatecontain
ort
solut
potenti
facilit
growth
etec
bacteria
express
pili
product
sta
enterotoxin
small
intestin
neonat
calv
particularli
suscept
infect
salmonella
enterica
subsp
enterica
immatur
immun
system
suspect
high
abomas
ph
first
hour
life
calv
endem
infect
farm
expos
salmonella
immedi
birth
ingest
fece
colostrum
dam
first
week
life
environ
via
contamin
colostrum
milk
feed
utensil
farm
personnel
wean
drink
water
continu
replenish
water
tank
ph
cow
chronic
infect
may
shed
salmonellaml
milk
frequent
salmonella
readili
multipli
pool
unrefriger
wast
milk
outbreak
salmonellosi
calv
associ
feed
unrefriger
wast
milk
colostrum
anoth
cow
one
studi
found
dairi
calv
california
dairi
shed
salmonella
stool
within
hour
birth
shed
salmonella
within
day
birth
calv
develop
agedepend
resist
salmonella
appear
associ
develop
function
rumen
presenc
divers
small
intestin
bacteri
popul
low
abomas
ph
optimum
ph
salmonella
growth
gener
accept
fall
salmonella
sensit
destruct
exposur
low
ph
abomas
acid
therefor
provid
natur
barrier
ingest
salmonella
salmonella
isol
small
number
cattl
kill
ph
multipli
ph
r
maintain
low
abomas
ph
therefor
decreas
number
viabl
salmonella
bacteria
reach
small
intestin
therebi
increas
nonspecif
resist
intestin
colon
decreas
incid
infect
clinic
diseas
presenc
bacteria
inhibit
growth
salmonella
inhibit
appear
mediat
bacteri
metabol
wast
product
short
chain
fatti
acid
acet
propion
butyr
inhibit
growth
salmonella
even
concentr
low
mmoll
frequent
found
ort
solut
administ
diarrheic
calv
find
suggest
addit
acet
propion
may
benefici
effect
separ
obtain
constabl
sodium
coupl
intestin
absorpt
system
alkalin
prevent
excess
intestin
alkalin
sourc
nutrit
probiot
lyophil
live
bacteri
cultur
ad
anim
feed
administ
individu
anim
attempt
improv
perform
increas
resist
enter
pathogen
probiot
may
correctli
term
directf
microbi
recent
emphasi
differenti
probiot
prebiot
latter
food
nourish
benefici
bacteria
alreadi
resid
digest
tract
bifidobacteria
lactobacillu
speci
administr
probiot
diarrheic
calv
done
dairi
herd
practic
current
recommend
daili
administr
lyophil
lacticacid
produc
bacteria
milk
first
day
life
effect
c
parvum
infect
dairi
calv
california
calv
spontan
diarrhea
administr
lactobacillu
rhamnosu
gg
extens
studi
probiot
isol
human
gastrointestin
tract
therapi
diarrhea
chang
mortal
rate
incid
diarrhea
real
concern
result
recent
studi
neonat
foal
indic
administr
differ
lactobacillu
strain
prevent
diarrhea
associ
develop
diarrhea
clinic
abnorm
requir
veterinari
intervent
foal
studi
contradict
wide
held
belief
probiot
ca
nt
hurt
result
recent
studi
field
condit
germani
indic
prophylact
administr
probiot
bacteria
e
coli
strain
nissl
first
day
life
calv
unknown
statu
passiv
transfer
associ
signific
decreas
number
calv
develop
diarrhea
base
report
administr
e
coli
strain
nissl
may
help
prevent
treat
diarrhea
calv
addit
studi
need
product
sold
germani
trade
name
ponsocol
prevent
neonat
diarrhea
administr
intestin
protect
kaolin
natur
hydrat
aluminum
silic
activ
attapulgit
hydrat
magnesium
aluminum
trisil
pectin
natur
polygalacturon
acid
absorb
activ
charcoal
kaolin
attapulgit
recommend
protect
believ
protect
damag
intestin
mucosa
absorb
purportedli
neutral
lumin
toxin
prevent
bind
epitheli
cell
receptor
data
treatment
efficaci
avail
calv
importantli
result
recent
prospect
random
studi
indic
nonantibiot
treatment
calf
diarrhea
includ
bismuth
kaolinpectin
activ
attapulgit
activ
charcoal
result
longer
durat
treatment
increas
risk
morbid
mortal
compar
oral
antibiot
milk
replac
neomycin
sulfat
chlortetracyclin
hydrochlorid
parenter
administr
ceftiofur
hydrochlorid
mgkg
day
intestin
motil
alter
diarrhea
chang
mean
abnorm
motil
deleteri
therapeut
manipul
intestin
motil
calv
diarrhea
benefici
drug
inhibit
intestin
motil
indic
part
routin
treatment
calf
diarrhea
even
though
induct
complet
intestin
paralysi
may
view
success
treatment
calf
diarrhea
success
measur
basi
fecal
product
inde
daili
volum
fece
import
criterion
treatment
success
mere
starvat
calf
would
view
excel
therapi
reduct
intestin
motil
mean
toxin
bacteria
present
intestin
lumen
flush
away
increas
local
concentr
possibl
pathogen
effect
administr
agent
decreas
intestin
motil
hyoscin
nbutylbromid
atropin
recommend
despit
widespread
use
data
treatment
efficaci
calv
natur
acquir
diarrhea
avail
one
studi
calv
nutrit
diarrhea
caus
sucros
administr
found
hyoscinedipyron
caus
modest
reduct
fecal
water
loss
combin
administr
central
act
muscarin
antagonist
dexetimid
benzetimid
mgkg
bodyweight
im
antibiot
caus
faster
resolut
diarrhea
calv
administr
antibiot
alon
dexetimid
wide
use
treat
neurolepticinduc
parkinson
human
role
treatment
calf
diarrhea
remain
unclear
product
deriv
mycobacteri
cell
wall
extract
develop
unit
state
parenter
administr
product
immunoboost
bionich
anim
health
usa
inc
first
hour
life
purportedli
decreas
preval
diarrhea
suggest
product
may
efficaci
ancillari
treatment
calf
diarrhea
howev
peerreview
public
document
treatment
efficaci
appear
avail
veterinari
homeopathi
increas
popular
particularli
europ
prioriti
often
given
veterinari
homeopath
treatment
rather
allopath
veterinari
medicin
organ
farm
homeopath
agent
podophyllum
deriv
podophyllum
peltatum
mayappl
use
medicin
nativ
american
indian
lax
treatment
intestin
parasit
result
doubleblind
placebocontrol
clinic
trial
podophyllum
dose
state
calv
diarrhea
sweden
indic
podophyllum
effect
durat
diarrhea
presenc
depress
inappet
fever
allicin
sulfurcontain
compon
garlic
prevent
growth
bacteria
fungi
virus
protozoa
effect
weight
gain
durat
diarrhea
due
c
parvum
calv
anecdot
report
use
nutmeg
treatment
calf
diarrhea
exist
treatment
efficaci
formal
evalu
oregano
contain
oil
carvacrol
thymol
antimicrobi
activ
effect
oral
administr
oregano
essenti
oil
mgkg
bodyweight
mouth
daili
compar
purport
posit
control
oral
neomycin
mgkg
bodyweight
mouth
daili
calv
natur
acquir
diarrhea
greec
differ
durat
diarrhea
sever
diarrhea
observ
two
treatment
studi
document
efficaci
oral
neomycin
label
dose
treat
calv
natur
acquir
diarrhea
appear
publish
peerreview
journal
oregano
recommend
adjunct
treatment
calf
diarrhea
adjunct
treatment
calv
diarrhea
routin
undertaken
calv
system
sign
ill
manifest
fever
inappet
lethargi
ancillari
treatment
document
efficaci
undifferenti
calf
diarrhea
includ
parenter
administr
antimicrobi
predominantli
gramneg
spectrum
activ
parenter
administr
nsaid
agent
meloxicam
flunixin
meglumin
continu
feed
cow
milk
recommend
adjunct
treatment
protocol
similar
use
lead
dairi
veterinarian
europ
final
halofuginon
azithromycin
document
efficaci
calv
diarrhea
caus
c
parvum
administr
may
consid
calv
document
suspect
cryptosporidiosi
